[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Shah et al., 2023 - Google Patents

In Silico Studies of Indole Derivatives as Antibacterial Agents

Shah et al., 2023

View HTML
Document ID
14002148342806810042
Author
Shah M
Kumar A
Singh A
Singh H
Narasimhan B
Kumar P
Publication year
Publication venue
Journal of Pharmacopuncture

External Links

Snippet

Methods In this study, we used a multiple linear regressions (MLR) approach to construct a 2D quantitative structure activity relationship of 14 reported indole derivatives. It was performed on the reported antibacterial activity data of 14 compounds based on theoretical …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
    • G06F19/322—Management of patient personal data, e.g. patient records, conversion of records or privacy aspects
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3456—Computer-assisted prescription or delivery of medication, e.g. prescription filling or compliance checking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/70—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds
    • G06F19/706—Chemoinformatics, i.e. data processing methods or systems for the retrieval, analysis, visualisation, or storage of physicochemical or structural data of chemical compounds for drug design with the emphasis on a therapeutic agent, e.g. ligand-biological target interactions, pharmacophore generation
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
    • G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
    • G06F19/3406—Local monitoring or local control of medical devices, e.g. configuration parameters, graphical user interfaces [GUI] or dedicated hardware interfaces
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/16—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for molecular structure, e.g. structure alignment, structural or functional relations, protein folding, domain topologies, drug targeting using structure data, involving two-dimensional or three-dimensional structures
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/28—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for programming tools or database systems, e.g. ontologies, heterogeneous data integration, data warehousing or computing architectures
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
    • G06F19/10—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology
    • G06F19/18—Bioinformatics, i.e. methods or systems for genetic or protein-related data processing in computational molecular biology for functional genomics or proteomics, e.g. genotype-phenotype associations, linkage disequilibrium, population genetics, binding site identification, mutagenesis, genotyping or genome annotation, protein-protein interactions or protein-nucleic acid interactions
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06F—ELECTRICAL DIGITAL DATA PROCESSING
    • G06F17/00—Digital computing or data processing equipment or methods, specially adapted for specific functions
    • G06F17/30—Information retrieval; Database structures therefor; File system structures therefor
    • G06F17/30861—Retrieval from the Internet, e.g. browsers

Similar Documents

Publication Publication Date Title
Slater et al. The compromise of virtual screening and its impact on drug discovery
Santos et al. A comprehensive map of molecular drug targets
Chen et al. From laptop to benchtop to bedside: structure-based drug design on protein targets
Leeson et al. The influence of the'organizational factor'on compound quality in drug discovery
Hou et al. How to improve docking accuracy of AutoDock4. 2: a case study using different electrostatic potentials
Singh et al. NMR-fragment based virtual screening: a brief overview
Nicola et al. Public domain databases for medicinal chemistry
Turner et al. Pharmacokinetic parameter prediction from drug structure using artificial neural networks
Ortega et al. In silico pharmacology for a multidisciplinary drug discovery process
Southan et al. Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds
Gokhale et al. FLT3 inhibitor design using molecular docking based virtual screening for acute myeloid leukemia
Natarajan et al. E-pharmacophore-based virtual screening to identify GSK-3β inhibitors
Joseph et al. Lysines and Arginines play non-redundant roles in mediating chemokine-glycosaminoglycan interactions
Martorana et al. The repurposing of old drugs or unsuccessful lead compounds by in silico approaches: new advances and perspectives
Mehta et al. Molecular modeling of histamine receptors—recent advances in drug discovery
Parida et al. Insight into the screening of potential beta-lactamase inhibitors as anti-bacterial chemical agents through pharmacoinformatics study
Shah et al. In Silico Studies of Indole Derivatives as Antibacterial Agents
Dhanasekaran et al. Anti-fungal potential of structurally diverse FDA-approved therapeutics targeting secreted aspartyl proteinase (SAP) of Candida albicans: an in silico drug repurposing approach
Khan et al. Modern methods & web resources in drug design & discovery
Obakachi et al. Structural based investigation of novel pyrazole-thiazole Hybrids as dual CDK-1 and CDK-2 inhibitors for cancer chemotherapy
Azmi et al. In Silico characterization of withania coagulans bioactive compounds as potential inhibitors of hydroxymethylglutaryl (HMG-CoA) reductase of mus musculus
Arwansyah et al. Molecular Recognition of Moringa oleifera Active Compounds for Stunted Growth Prevention Using Network Pharmacology and Molecular Modeling Approach
Allam et al. Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors
Nepravishta et al. Fast Quantitative Validation of 3D Models of Low-Affinity Protein–Ligand Complexes by STD NMR Spectroscopy
Li et al. HybridMolDB: a manually curated database dedicated to hybrid molecules for chemical biology and drug discovery